694-695 / 1726
➢
Stage I serous and clear cell
•
103 patients: 26% non-invasive; 58% <50% invasion
•
34% received adjuvant chemotherapy
•
5-year isolated pelvic recurrence rate 4%, locoregional recurrence 7%
•
5-year OS 84%
➢
Vaginal brachytherapy alone sufficient in stage IA
Barney BM. IJROBP 2013
Serous and clear cell